Ipratropium bromide/Xylometazoline Hydrochloride

异丙托溴铵/盐酸赛洛唑啉

Report date: 2022/04/07 15:22:11

Base Information

Drug NameIpratropium bromide/Xylometazoline Hydrochloride

Drug Alias NameXylometazoline Hydrochloride/Ipratropium bromide盐酸赛洛唑啉/异丙托溴铵ipratropium bromide and xylometazoline hydrochloridexylometazoline hydrochloride and ipratropium bromideZyComb

ClassificationSmall molecules

Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsAlpha adrenergic receptor agonists

TargetsMuscarinic acetylcholine receptorAlpha adrenergic receptor

Therapy Area/IndicationsCommon Cold

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Ipratropium bromide Xylometazoline Hydrochloride

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesTakeda Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsCommon Cold

Inactive IndicationsN/A

Other Information

ATC CodeR01AA07R01AB06S01GA03